Lexaria Expands COVID-19 Drug Research Program Utilizing Proprietary DehydraTECH
Remdesivir is one of several drugs to be evaluated KELOWNA, BC / ACCESSWIRE / December 22, 2020 / Lexaria Bioscience...
Day: December 22, 2020
Venus Concept Inc. Announces Pricing of $22.5 Million Public Offering
TORONTO, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (Nasdaq: VERO), a global medical...
World Telehealth Initiative Receives Investment from Intel Corporation to Expand Access to Medical Care in Vulnerable Communities Around the World
Utilizing this investment, WTI can continue providing healthcare to developing communities through Teladoc Health’s virtual care platformSANTA BARBARA, Calif., Dec....
Acer Therapeutics Announces Full Enrollment of Pivotal Bioequivalence Trial of ACER-001 for Urea Cycle Disorders
Topline trial results expected in Q1 2021; targeting a pre-NDA meeting with FDA in Q2 2021NEWTON, Mass., Dec. 22, 2020...
TOMI Service Network Members Experience a Surge in SteraMist Business
FREDERICK, Md., Dec. 22, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ:TOMZ), a global company specializing in disinfection...
Resonant Appoints Industry Thought Leader Dr. Peter Gammel to Advisory Board
Semiconductor Industry Veteran to Join Advisory LeadershipAUSTIN, Texas, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader...
Monopar Announces Issuance of U.S. Patent Covering Compositions of Matter for a Novel Family of Camsirubicin Analogs
-Issued patent expands and strengthens Monopar’s existing camsirubicin IP portfolio-Phase 2 initiation for camsirubicin in advanced soft tissue sarcoma remains...
Cocrystal Pharma Selects Lead Compound for Further Development Against Coronaviruses
CDI-45205 holds potential as a therapeutic and as a prophylactic to protect against coronavirus transmission, including SARS-CoV-2 BOTHELL, Wash., Dec....
Grey Cloak Tech Completes Successful Pilot Study on its Fuel4Thought™ Migraine Formula with Positive Results
Fuel4Thought™ proprietary Migraine formulation is similar to their recently released Brain Booster, but scientifically designed to try and provide millions...
Philips, BioIntelliSense and University of Colorado receive U.S. Department of Defense funding for early COVID-19 detection
BioIntelliSense_Sticker Clinicians_view_patient_data_on_tablet-ALI-global December 22, 2020 In 2,500-person trial, partners to validate FDA-cleared BioSticker for clinical confidence in detecting infection Cambridge,...
TRACON Pharmaceuticals Announces $8.8 Million Registered Direct Offering
SAN DIEGO, Dec. 22, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the...
Eyesight Max Reviews – Best Vision Loss Supplement? – Product Review by Mike Vaughn
Eyesight Max is a supplement that supports your vision, no matter what age you are and no matter how bad...
Option Care Health to Participate in Upcoming Virtual Investor Conference
BANNOCKBURN, Ill., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest...
Inspire Medical Systems, Inc. to Present at the 39th Annual J.P. Morgan Healthcare Conference
MINNEAPOLIS, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on...
Kiniksa Announces Data from U.S. Investigator-Initiated Study of Mavrilimumab in Severe COVID-19 Pneumonia and Hyperinflammation
- Early signal of efficacy with trends toward lower mortality and shorter duration of mechanical ventilation in patients treated with...
Vaxcyte Promotes Andrew Guggenhime to President and Chief Financial Officer
FOSTER CITY, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking...
Carrot Enters Global Market for Tobacco Cessation with CE Mark Certification for its Breath Sensor
Clinically Proven to Increase the Motivation to Quit, the Company’s Device is the First Ever FDA-Cleared Breath Sensor for Consumer...
Novus Therapeutics Announces Results of Special Meeting of Stockholders
IRVINE, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biopharmaceutical company focused...
SCYNEXIS Announces Closing of $85 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants
JERSEY CITY, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq: SCYX) today announced the closing of its previously...
Cyclacel Pharmaceuticals Announces at-the-market $7 Million Strategic Investment by Fundamental Investor Acorn Bioventures
- Strategic investment from single biotech-focused institutional investor - - Enables clinical development of both fadraciclib and CYC140 in hematological...